| 1. |
|
|
| 2. |
- Rico-Pasto, M., et al.
(författare)
-
Dissipation Reduction and Information-to-Measurement Conversion in DNA Pulling Experiments with Feedback Protocols
- 2021
-
Ingår i: Physical Review X. - 2160-3308. ; 11:3
-
Tidskriftsartikel (refereegranskat)abstract
- Information-to-energy conversion with feedback measurement stands as one of the most intriguing aspects of the thermodynamics of information in the nanoscale. To date, experiments have focused on feedback protocols for work extraction. Here we address the novel case of dissipation reduction in nonequilibrium systems with feedback. We perform pulling experiments on DNA hairpins with optical tweezers, with a general feedback protocol based on multiple measurements that includes either discrete-time or continuous-time feedback. While feedback can reduce dissipation, it remains unanswered whether it also improves free-energy determination (information-to-measurement conversion). We define thermodynamic information as the natural logarithm of the feedback efficacy, a quantitative measure of the efficiency of information-to-energy and information-to-measurement conversion in feedback protocols. We find that discrete- and continuous-time feedback reduces dissipation by roughly kBT without improvement in free-energy determination. Remarkably, a feedback strategy (defined as a correlated sequence of feedback protocols) further reduces dissipation, enhancing information-to-measurement efficiency. Our study underlines the role of temporal correlations to develop feedback strategies for efficient information-to-measurement conversion in small systems.
|
|
| 3. |
- Aebi, S, et al.
(författare)
-
Differential efficacy of three cycles of CMF followed by tamoxifen in patients with ER-positive and ER-negative tumors: Long-term follow up on IBCSG Trial IX
- 2011
-
Ingår i: ANNALS OF ONCOLOGY. - 0923-7534. ; 22:9, s. 1981-1987
-
Tidskriftsartikel (refereegranskat)abstract
- Abstract: Background: The benefit of adjuvant chemotherapy in postmenopausal patients with estrogen receptor (ER)positive lymph node-negative breast cancer is being reassessed. Patients and methods: After stratification by ER status, 1669 postmenopausal patients with operable lymph nodenegative breast cancer were randomly assigned to three 28-day courses of 'classical' CMF (cyclophosphamide, methotrexate, 5-fluorouracil) chemotherapy followed by tamoxifen for 57 months (CMF/tamoxifen) or to tamoxifen alone for 5 years. Results: ERs were positive in 81% of tumors. At a median follow-up of 13.1 years, patients with ER-positive breast cancers did not benefit from CMF [13-year disease-free survival (DFS) 64% CMF/tamoxifen, 66% tamoxifen; P = 0.99], whereas CMF substantially improved the prognosis of patients with ER-negative breast cancer (13-year DFS 73% versus 57%, P = 0.001). Similarly, breast cancer-free interval (BCFI) was identical in the ER-positive cohort but significantly improved by chemotherapy in the ER-negative cohort (13-year BCFI 80% versus 63%, P = 0.001). CMF had no influence on second nonbreast malignancies or deaths from other causes. Conclusion: CMF is not beneficial in postmenopausal patients with node-negative ER-positive breast cancer but is highly effective within the ER-negative cohort. In the future, other markers of chemotherapy response may define a subset of patients with ER-positive tumors who may benefit from adjuvant chemotherapy.
|
|
| 4. |
- Colleoni, M, et al.
(författare)
-
Timing of CMF chemotherapy in combination with tamoxifen in postmenopausal women with breast cancer: role of endocrine responsiveness of the tumor.
- 2005
-
Ingår i: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. - : Elsevier BV. - 0923-7534. ; 16:5, s. 716-25
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Controversy persists about whether chemotherapy benefits all breast cancer patients. PATIENTS AND METHODS: In the International Breast Cancer Study Group (IBCSG) trial VII, 1212 postmenopausal patients with node-positive disease were randomized to receive tamoxifen for 5 years or tamoxifen plus three concurrent courses of cyclophosphamide, methotrexate and 5-fluorouracil ('classical' CMF) chemotherapy, either early, delayed or both. In IBCSG trial IX, 1669 postmenopausal patients with node-negative disease were randomized to receive either tamoxifen alone or three courses of adjuvant classical CMF prior to tamoxifen. Results were assessed according to estrogen receptor (ER) content of the primary tumor. RESULTS: For patients with node-positive, ER-positive disease, adding CMF either early, delayed or both reduced the risk of relapse by 21% (P=0.06), 26% (P=0.02) and 25% (P=0.02), respectively, compared with tamoxifen alone. There was no difference in disease-free survival when CMF was given prior to tamoxifen in patients with node-negative, ER-positive tumors. CONCLUSIONS: CMF given concurrently (early, delayed or both) with tamoxifen was more effective than tamoxifen alone for patients with node-positive, endocrine-responsive breast cancer, supporting late administration of chemotherapy even after commencement of tamoxifen. In contrast, sequential CMF and tamoxifen for patients with node-negative, endocrine-responsive disease was ineffective.
|
|
| 5. |
- Giuffrida, L., et al.
(författare)
-
Manipulation of laser-accelerated proton beam profiles by nanostructured and microstructured targets
- 2017
-
Ingår i: Physical Review Accelerators and Beams. - 2469-9888. ; 20:8, s. 081301-
-
Tidskriftsartikel (refereegranskat)abstract
- Nanostructured and microstructured thin foils have been fabricated and used experimentally as targets to manipulate the spatial profile of proton bunches accelerated through the interaction with high intensity laser pulses (6 x 1019 W/cm(2)). Monolayers of polystyrene nanospheres were placed on the rear surfaces of thin plastic targets to improve the spatial homogeneity of the accelerated proton beams. Moreover, thin targets with grating structures of various configurations on their rear sides were used tomodify the proton beam divergence. Experimental results are presented, discussed, and supported by 3D particle-in-cell numerical simulations.
|
|
| 6. |
- Giuffrida, L., et al.
(författare)
-
Nano and micro structured targets to modulate the spatial profile of laser driven proton beams
- 2017
-
Ingår i: Journal of Instrumentation. - 1748-0221. ; 12:3, s. article no C03040 -
-
Tidskriftsartikel (refereegranskat)abstract
- Nano and micro structured thin (μ m-scale) foils were designed, fabricated and irradiated with the high intensity laser system operating at LLC (Lund Laser Centre, Sweden) in order to systematically study and improve the main proton beam parameters. Nano-spheres deposited on the front (laser irradiated) surface of a flat Mylar foil enabled a small enhancement of the maximum energy and number of the accelerated protons. Nano-spheres on the rear side allowed to modify the proton beam spatial profile. In particular, with nanospheres deposited on the rear of the target, the proton beam spatial homogeneity was clearly enhanced. Silicon nitride thin foils having micro grating structures (with different step dimensions) on the rear surface were also used as targets to influence the divergence of the proton beam and drastically change its shape through a sort of stretching effect. The target fabrication process used for the different target types is described, and representative experimental results are shown and discussed along with supporting 3D particle-in-cell simulations. © 2017 IOP Publishing Ltd and Sissa Medialab srl.
|
|
| 7. |
- Gruber, G, et al.
(författare)
-
Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer.
- 2008
-
Ingår i: Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. - : Elsevier BV. - 1569-8041. ; 19:8, s. 1393-401
-
Tidskriftsartikel (refereegranskat)abstract
- BACKGROUND: Extracapsular tumor spread (ECS) has been identified as a possible risk factor for breast cancer recurrence, but controversy exists regarding its role in decision making for regional radiotherapy. This study evaluates ECS as a predictor of local, axillary, and supraclavicular recurrence. PATIENTS AND METHODS: International Breast Cancer Study Group Trial VI accrued 1475 eligible pre- and perimenopausal women with node-positive breast cancer who were randomly assigned to receive three to nine courses of classical combination chemotherapy with cyclophosphamide, methotrexate, and fluorouracil. ECS status was determined retrospectively in 933 patients based on review of pathology reports. Cumulative incidence and hazard ratios (HRs) were estimated using methods for competing risks analysis. Adjustment factors included treatment group and baseline patient and tumor characteristics. The median follow-up was 14 years. RESULTS: In univariable analysis, ECS was significantly associated with supraclavicular recurrence (HR = 1.96; 95% confidence interval 1.23-3.13; P = 0.005). HRs for local and axillary recurrence were 1.38 (P = 0.06) and 1.81 (P = 0.11), respectively. Following adjustment for number of lymph node metastases and other baseline prognostic factors, ECS was not significantly associated with any of the three recurrence types studied. CONCLUSIONS: Our results indicate that the decision for additional regional radiotherapy should not be based solely on the presence of ECS.
|
|
| 8. |
- Gruber, Günther, et al.
(författare)
-
Prognostic value of extracapsular tumor spread for locoregional control in premenopausal patients with node-positive breast cancer treated with classical cyclophosphamide, methotrexate, and fluorouracil: long-term observations from International Breast Cancer Study Group Trial VI.
- 2005
-
Ingår i: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. - 0732-183X. ; 23:28, s. 7089-97
-
Tidskriftsartikel (refereegranskat)abstract
- PURPOSE: We sought to determine retrospectively whether extracapsular spread (ECS) might identify a subgroup that could benefit from radiotherapy after mastectomy, especially patients with 1 to 3 positive lymph nodes (LN1-3+). PATIENTS AND METHODS: We randomized 1,475 premenopausal women with node-positive breast cancer to three, six, or nine courses of "classical" CMF (cyclophosphamide, methotrexate, and fluorouracil). After a review of all pathology forms, 933 patients (63%) had information on the presence or absence of ECS. ECS was present in 49.5%. The median follow-up was 10 years. RESULTS: In univariate analyses, ECS was associated with worse disease-free survival (DFS) and overall survival (OS). In multivariate analyses adjusting for tumor size, vessel invasion, surgery type, and age group, ECS remained significant (DFS: hazard ratio, 1.61; 95% CI, 1.34 to 1.93; P < .0001; OS: 1.67; 95% CI, 1.34 to 2.08; P < .0001). However, ECS was not significant when the number of positive nodes was added. The locoregional failure rate +/- distant failure (LRF +/- distant failure) within 10 years was estimated at 19% (+/- 2%) without ECS, versus 27% (+/- 2%) with ECS. The difference was statistically significant in univariate analyses, but not after adjusting for the number of positive nodes. No independent effect of ECS on DFS, OS, or LRF could be confirmed within the subgroup of 382 patients with LN1-3+ treated with mastectomy without radiotherapy. CONCLUSION: Our results do not support an independent prognostic value of ECS, nor its use as an indication for irradiation in premenopausal patients with LN1-3+ treated with classical CMF. However, we could not examine whether extensive ECS is of prognostic importance.
|
|
| 9. |
- Karlsson, Per, 1963, et al.
(författare)
-
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
- 2012
-
Ingår i: Annals of Oncology. - : Elsevier BV. - 0923-7534. ; 23:11, s. 2852-2858
-
Tidskriftsartikel (refereegranskat)abstract
- Rates and risk factors of local, axillary and supraclavicular recurrences can guide patient selection and target for postmastectomy radiotherapy (PMRT). Local, axillary and supraclavicular recurrences were evaluated in 8106 patients enrolled in 13 randomized trials. Patients received chemotherapy and/or endocrine therapy and mastectomy without radiotherapy. Median follow-up was 15.2 years. Ten-year cumulative incidence for chest wall recurrence of > 15% was seen in patients aged < 40 years (16.1%), with >= 4 positive nodes (16.5%) or 0-7 uninvolved nodes (15.1%); for supraclavicular failures > 10%: >= 4 positive nodes (10.2%); for axillary failures of > 5%: aged < 40 years (5.1%), unknown primary tumor size (5.2%), 0-7 uninvolved nodes (5.2%). In patients with 1-3 positive nodes, 10-year cumulative incidence for chest wall recurrence of > 15% were age < 40, peritumoral vessel invasion or 0-7 uninvolved nodes. Age, number of positive nodes and number of uninvolved nodes were significant parameters for each locoregional relapse site. PMRT to the chest wall and supraclavicular fossa is supported in patients with >= 4 positive nodes. With 1-3 positive nodes, chest wall PMRT may be considered in patients aged < 40 years, with 0-7 uninvolved nodes or with vascular invasion. The findings do not support PMRT to the dissected axilla.
|
|
| 10. |
- Marzoli, Andrea, et al.
(författare)
-
The Central Atlantic Magmatic Province (CAMP) in Morocco
- 2019
-
Ingår i: Journal of Petrology. - : Oxford University Press (OUP). - 0022-3530 .- 1460-2415. ; 60:5, s. 945-996
-
Tidskriftsartikel (refereegranskat)abstract
- The Central Atlantic Magmatic Province (CAMP) is a large igneous province (LIP) composed of basic dykes, sills, layered intrusions and lava flows emplaced before Pangea break-up and currently distributed on the four continents surrounding the Atlantic Ocean. One of the oldest, best preserved and most complete sub-provinces of the CAMP is located in Morocco. Geochemical, geochronologic, petrographic and magnetostratigraphic data obtained in previous studies allowed identification of four strato-chemical magmatic units, i.e. the Lower, Intermediate, Upper and Recurrent units. For this study, we completed a detailed sampling of the CAMP in Morocco, from the Anti Atlas in the south to the Meseta in the north. We provide a complete mineralogical, petrologic (major and trace elements on whole-rocks and minerals), geochronologic (40Ar/39Ar and U–Pb ages) and geochemical set of data (including Sr–Nd–Pb–Os isotope systematics) for basaltic and basaltic–andesitic lava flow piles and for their presumed feeder dykes and sills. Combined with field observations, these data suggest a very rapid (<0·3 Ma) emplacement of over 95% of the preserved magmatic rocks. In particular, new and previously published data for the Lower to Upper unit samples yielded indistinguishable 40Ar/39Ar (mean age = 201·2 ± 0·8 Ma) and U–Pb ages (201·57 ± 0·04 Ma), suggesting emplacement coincident with the main phase of the end-Triassic biotic turnover (c.201·5 to 201·3 Ma). Eruptions are suggested to have been pulsed with rates in excess of 10 km3/year during five main volcanic pulses, each pulse possibly lasting only a few centuries. Such high eruption rates reinforce the likelihood that CAMP magmatism triggered the end-Triassic climate change and mass extinction. Only the Recurrent unit may have been younger but by no more than 1 Ma. Whole-rock and mineral geochemistry constrain the petrogenesis of the CAMP basalts. The Moroccan magmas evolved in mid-crustal reservoirs (7–20 km deep) where most of the differentiation occurred. However, a previous stage of crystallization probably occurred at even greater depths. The four units cannot be linked by closed-system fractional crystallization processes, but require distinct parental magmas and/or distinct crustal assimilation processes. EC-AFC modeling shows that limited crustal assimilation (maximum c.5–8% assimilation of e.g. Eburnean or Pan-African granites) could explain some, but not all the observed geochemical variations. Intermediate unit magmas are apparently the most contaminated and may have been derived from parental magmas similar to the Upper basalts (as attested by indistinguishable trace element contents in the augites analysed for these units). Chemical differences between Central High Atlas and Middle Atlas samples in the Intermediate unit could be explained by distinct crustal contaminants (lower crustal rocks or Pan-African granites for the former and Eburnean granites for the latter). The CAMP units in Morocco are likely derived from 5–10% melting of enriched peridotite sources. The differences observed in REE ratios for the four units are attributed to variations in both source mineralogy and melting degree. In particular, the Lower basalts require a garnet peridotite source, while the Upper basalts were probably formed from a shallower melting region straddling the garnet–spinel transition. Recurrent basalts instead are relatively shallow-level melts generated mainly from spinel peridotites. Sr–Nd–Pb–Os isotopic ratios in the CAMP units from Morocco are similar to those of other CAMP sub-provinces and suggest a significant enrichment of the mantle-source regions by subducted crustal components. The enriched signature is attributed to involvement of about 5–10% recycled crustal materials introduced into an ambient depleted or PREMA-type mantle, while involvement of mantle-plume components like those sampled by present-day Central Atlantic Ocean Island Basalts (OIB, e.g. Cape Verde and Canary Islands) is not supported by the observed compositions. Only Recurrent basalts may possibly reflect a Central Atlantic plume-like signature similar to the Common or FOZO components.
|
|
